EMM is a poor prognostic factor for MM, usually with a high tumor load, severe anemia, thrombocytopenia, hypercalcemia, and renal insufficiency, accompanied by increased serum LDH and β2-microglobulin levels (2). This evidence concerns the gene HLA-G and anemia.